Butyrylcarnitine

Butyrylcarnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 61 references associated with Butyrylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Butyrylcarnitine

Download all related citations
Per page 10 20 | Total 19
Authors Title Published Journal PubMed Link
Vorkas PA et al. Metabolic Phenotypes of Carotid Atherosclerotic Plaques Relate to Stroke Risk: An Exploratory Study. 2016 Eur J Vasc Endovasc Surg pmid:27231199
Cheng ML et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. 2015 J. Am. Coll. Cardiol. pmid:25881932
Alexandre-Gouabau MC et al. Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants. 2013 J. Proteome Res. pmid:23527880
Gallant NM et al. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. 2012 Mol. Genet. Metab. pmid:22424739
van Maldegem BT et al. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. 2010 Pediatr. Res. pmid:19952864
Forni S et al. Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis. 2010 Mol. Genet. Metab. pmid:20591710
Beattie SG et al. Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD. 2008 Hum. Gene Ther. pmid:18500942
Srinivas SR et al. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). 2007 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17855766
Merinero B et al. Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. 2006 J. Inherit. Metab. Dis. pmid:16906473
van Maldegem BT et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. 2006 JAMA pmid:16926354
Conlon TJ et al. Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector. 2006 Hum. Gene Ther. pmid:16409126
Hack A et al. Monitoring of ketogenic diet for carnitine metabolites by subcutaneous microdialysis. 2006 Pediatr. Res. pmid:16690958
Kuster T et al. Filter paper cards contaminated with EMLA cream produce artefacts on acylcarnitine analysis. 2004 J. Inherit. Metab. Dis. pmid:15669691
Nagan N et al. The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots. 2003 Mol. Genet. Metab. pmid:12706374
Koeberl DD et al. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. 2003 Pediatr. Res. pmid:12736383
Lozano P et al. Ester synthesis from trimethylammonium alcohols in dry organic media catalyzed by immobilized Candida antarctica lipase B. 2003 Biotechnol. Bioeng. pmid:12599262
Young SP et al. A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency. 2003 Clin. Chim. Acta pmid:14568186
Tyni T et al. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. 2002 Pediatr. Res. pmid:12084849
pmid:

Table of Content